Dr John S Tregoning
Imperial College London
H-index: 41
Europe-United Kingdom
Top articles of Dr John S Tregoning
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Robust and sensitive amplicon-based whole-genome sequencing assay of respiratory syncytial virus subtype A and B | Microbiology Spectrum | Tiina Talts Lucy G Mosscrop David Williams John S Tregoning Whitney Paulo | 2024/2/27 |
IL-1α is required for T cell driven weight loss after respiratory viral infection | Mucosal Immunology | Ziyin Wang Leah F Cuthbertson Chubicka Thomas Hadijatou J Sallah Lucy G Mosscrop | 2024/2/19 |
Optimising a linear ‘Doggybone’DNA vaccine for influenza virus through the incorporation of DNA targeting sequences and neuraminidase antigen | Discovery Immunology | Robert F Cunliffe David C Stirling Ilaria Razzano Valarmathy Murugaiah Emanuele Montomoli | 2024/1/3 |
Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines | Molecular Therapy-Nucleic Acids | John S Tregoning David C Stirling Ziyin Wang Katie E Flight Jonathan C Brown | 2023/3/14 |
Propylene glycol inactivates respiratory viruses and prevents airborne transmission | EMBO Molecular Medicine | Christine T Styles Jie Zhou Katie E Flight Jonathan C Brown Charlotte Lewis | 2023/12/7 |
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague | Frontiers in Microbiology | Robin John Shattock Voahangy Andrianaivoarimanana Paul F McKay Lovasoa Nomena Randriantseheno Valarmathy Murugaiah | 2023/11/2 |
LION: Taming RNA vaccine inflammation | Molecular Therapy | John S Tregoning | 2023/9/6 |
Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii | Journal of Infection | Sophie L Higham Stephen Baker Katie E Flight Aishwarya Krishna Paul Kellam | 2023/6/1 |
A Rhinovirus-A16 VP0 Vaccine Induces Homotypic Humoral and Cellular Immunity, and Following Heterotypic Rhinovirus-A01 Infection, Accelerates Virus Clearance and Induces Cross … | CJ Pyle ND Patel Z Wang JS Tregoning P Hamblin | 2023/5 | |
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice | Molecular Therapy-Nucleic Acids | Ziyin Wang Egon J Jacobus David C Stirling Stefanie Krumm Katie E Flight | 2023/12/12 |
Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets | Oxford open immunology | PF McKay J Zhou R Frise AK Blakney CR Bouton | 2022/1/1 |
Levels of influenza A virus defective viral genomes determine pathogenesis in the BALB/c mouse model | Journal of Virology | Rebecca Penn John S Tregoning Katie E Flight Laury Baillon Rebecca Frise | 2022/11/9 |
Respiratory syncytial virus after the SARS-CoV-2 pandemic—what next? | Lucy G Mosscrop Thomas C Williams John S Tregoning | 2022/10 | |
Group B Streptococcus (GBS) colonization is dynamic over time, whilst GBS capsular polysaccharides-specific antibody remains stable | Clinical and Experimental Immunology | IL Haeusler O Daniel C Isitt R Watts L Cantrell | 2022/8/1 |
Blocking T‐cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity | Immunology | Jamie FS Mann Paul F McKay Katja Klein Joshua Pankrac John S Tregoning | 2022/3 |
FLU FIGHTERS: HOW CHILDREN WHO GET THE NASAL INFLUENZA VACCINE PROTECT OTHERS FROM FLU | How to Fight Harmful Microbial Bugs and Superbugs? | Alice Halliday Mica Roan Tolosa-Wright Aime Afua Boakye John S Tregoning | 2021/9/1 |
738 Resident memory airway T cells protect against RSV infection in the absence of antibody | Ekaterina Kinnear Laura Lambert Jacqueline McDonald Hannah Cheeseman Lisa Caproni | 2021/8/1 | |
Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children | Cell Reports Medicine | Andre G Costa-Martins Karim Mane Benjamin B Lindsey Rodrigo LT Ogava Ícaro Castro | 2021/12/21 |
Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children | Clinical & Experimental Immunology | Megan E Cole Rhiannon Kundu Amina F Abdulla Nicholas Andrews Katja Hoschler | 2021/4 |
Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity | Journal of Experimental Medicine | Chloe J Pyle Lucia Labeur-Iurman Helen T Groves Franz Puttur Clare M Lloyd | 2021/10/19 |